Louisiana State Employees Retirement System Purchases New Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Louisiana State Employees Retirement System purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 19,900 shares of the company’s stock, valued at approximately $983,000.

A number of other large investors have also added to or reduced their stakes in the stock. Emerald Mutual Fund Advisers Trust acquired a new stake in Acadia Healthcare during the first quarter worth approximately $210,000. Paloma Partners Management Co acquired a new stake in Acadia Healthcare during the first quarter worth approximately $217,000. M&T Bank Corp acquired a new stake in Acadia Healthcare during the first quarter worth approximately $230,000. Teacher Retirement System of Texas acquired a new stake in Acadia Healthcare during the first quarter worth approximately $258,000. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in Acadia Healthcare by 224.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 6,290 shares of the company’s stock worth $274,000 after buying an additional 4,350 shares during the period.

Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded up 7.66% during mid-day trading on Friday, reaching $53.00. The company had a trading volume of 2,266,310 shares. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of 582.42 and a beta of 1.14. The firm’s 50 day moving average price is $48.48 and its 200-day moving average price is $43.71. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $56.20.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The firm had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a return on equity of 8.85% and a net margin of 0.30%. The firm’s revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.73 EPS. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post $2.44 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “[[title]]” was published by [[site]] and is the property of of [[site]]. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at [[permalink]].

A number of research firms have commented on ACHC. Mizuho increased their price target on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday. BidaskClub upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Leerink Swann cut Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, May 15th. Zacks Investment Research upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, April 28th. Finally, KeyCorp restated an “overweight” rating and issued a $51.00 price objective on shares of Acadia Healthcare in a research note on Thursday, June 1st. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $57.85.

In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 86,483 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the completion of the sale, the chief operating officer now directly owns 137,204 shares of the company’s stock, valued at approximately $6,095,973.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Reeve B. Waud sold 724,694 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $45.53, for a total value of $32,995,317.82. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 968,102 shares of company stock valued at $44,283,109. 11.10% of the stock is owned by company insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).